Showing 1,521 - 1,540 results of 100,755 for search '(( 5 ((ppm decrease) OR (nn decrease)) ) OR ( 5 ((we decrease) OR (a decrease)) ))', query time: 1.79s Refine Results
  1. 1521

    Scaling Laws for the Influence of Gravity and Its Gradient on Dropwise Condensation: A Simulation Study by Chen Ma (714759)

    Published 2024
    “…We also identify a critical gravitational acceleration determined by nucleation density, above which a counterintuitive trend emerges: the heat flux decreases with increasing gravitational acceleration. …”
  2. 1522

    Scaling Laws for the Influence of Gravity and Its Gradient on Dropwise Condensation: A Simulation Study by Chen Ma (714759)

    Published 2024
    “…We also identify a critical gravitational acceleration determined by nucleation density, above which a counterintuitive trend emerges: the heat flux decreases with increasing gravitational acceleration. …”
  3. 1523
  4. 1524

    CC-1<sup>+</sup> immunostained cell numbers decrease by 2 days after TBI and return to control levels by 5 weeks. by Krista A. Dent (709531)

    Published 2015
    “…Panels show contralateral (Contra) and ipsilateral (Ipsi) external capsule (EC) at (A,B) 2 days (2d), (C,D) 2 weeks (2w) and (E,F) 5 weeks (5w) (G) In the external capsule numbers of CC-1<sup>+</sup> oligodendrocytes were decreased by 2d after injury, remained decreased at 2 weeks and returned to normal levels by 5 weeks. …”
  5. 1525
  6. 1526
  7. 1527
  8. 1528

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
  9. 1529

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
  10. 1530
  11. 1531
  12. 1532
  13. 1533

    In we present the number of modules determined by DMSP on various values of connectivity density by Ioannis A Maraziotis (86282)

    Published 2011
    “…When we apply stricter criteria (as in red dotted line) there is a slight decrease in the number of the modules but at the same time the connectivity density values are better. …”
  14. 1534
  15. 1535
  16. 1536
  17. 1537
  18. 1538
  19. 1539

    Decrease of NF-κB activity in tumor tissue of CCR5<sup>−/−</sup> mice. by Ju Kyoung Song (324058)

    Published 2013
    “…<p><b>A</b>, The DNA binding activity of NF-κB was determined in the nuclear extracts of the CCR5<sup>−/−</sup> mice and CCR5<sup>+/+</sup> mice tumor tissues by EMSA described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0033747#s4" target="_blank">material and methods</a>. …”
  20. 1540